Antibody-modified liposomes for cancer chemotherapy.
Expert Opin Drug Deliv
; 5(9): 1003-25, 2008 Sep.
Article
em En
| MEDLINE
| ID: mdl-18754750
ABSTRACT
BACKGROUND:
Liposomes, phospholipids, nanosized bubbles with a bilayered membrane structure, have drawn a lot of interest as pharmaceutical carriers for drugs and genes. In particular, liposomes are widely used for drug delivery into tumors.OBJECTIVE:
In many cases, to enhance the efficacy of the liposomal drugs, drug-loaded liposomes are targeted to the tumors by means of different specific ligands, such as monoclonal antibodies. Thus, this review analyzes the application of antibody-targeted liposomes loaded with various chemotherapeutic agents and various liposomal products under development at experimental and preclinical level.METHODS:
The papers published on the subject of cancer-targeted liposomes mainly over the last 10 - 15 years are discussed.CONCLUSION:
Antibody-targeted liposomes loaded with anticancer drugs demonstrate high potential for clinical applications.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Lipossomos
/
Anticorpos Monoclonais
/
Antineoplásicos
Limite:
Animals
/
Humans
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article